BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33492750)

  • 1. Age-related differences in morbidity and mortality after surgery for primary clinical T4 and locally recurrent rectal cancer.
    Ketelaers SHJ; Voogt ELK; Simkens GA; Bloemen JG; Nieuwenhuijzen GAP; de Hingh IHJ; Rutten HJT; Burger JWA; Orsini RG
    Colorectal Dis; 2021 May; 23(5):1141-1152. PubMed ID: 33492750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
    van Ham NCM; Glazemakers S; van der Ende-van Loon M; Nieuwenhuijzen GAP; Rutten HJT; Tolenaar JL; Jacobs A; Burger JWA; Ketelaers SHJ; Bloemen JG
    Eur J Surg Oncol; 2024 Jun; 50(6):108259. PubMed ID: 38552415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of surgery for locally recurrent and second recurrent rectal cancer with metastatic disease.
    Tanaka A; Uehara K; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Surg Oncol; 2020 Dec; 35():328-335. PubMed ID: 32979698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 7. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
    Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts.
    van Geffen EGM; Langhout JMA; Hazen SJA; Sluckin TC; van Dieren S; Beets GL; Beets-Tan RGH; Borstlap WAA; Burger JWA; Horsthuis K; Intven MPW; Aalbers AGJ; Havenga K; Marinelli AWKS; Melenhorst J; Nederend J; Peulen HMU; Rutten HJT; Schreurs WH; Tuynman JB; Verhoef C; de Wilt JHW; Marijnen CAM; Tanis PJ; Kusters M; On Behalf Of The Dutch Snapshot Research Group
    Eur J Cancer; 2024 May; 202():114021. PubMed ID: 38520925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominosacral resection: long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer.
    Bosman SJ; Vermeer TA; Dudink RL; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
    Eur J Surg Oncol; 2014 Jun; 40(6):699-705. PubMed ID: 24679359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?
    van Rees JM; Nordkamp S; Harmsen PW; Rutten H; Burger JWA; Verhoef C
    Eur J Surg Oncol; 2023 Sep; 49(9):106865. PubMed ID: 37002176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Westberg K; Palmer G; Hjern F; Johansson H; Holm T; Martling A
    Eur J Surg Oncol; 2018 Jan; 44(1):100-107. PubMed ID: 29224985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
    Swartjes H; van Rees JM; van Erning FN; Verheij M; Verhoef C; de Wilt JHW; Vissers PAJ; Koëter T
    Ann Surg Oncol; 2023 Jul; 30(7):3915-3924. PubMed ID: 36790731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Holm T; Martling A
    Br J Surg; 2019 May; 106(6):790-798. PubMed ID: 30776087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and subsequent prognosis in locally recurrent rectal cancer: a multicenter retrospective study of 498 patients.
    Matsuyama T; Yamauchi S; Masuda T; Kikuchi A; Tokunaga M; Sugihara K; Kinugasa Y;
    Int J Colorectal Dis; 2021 Jun; 36(6):1243-1250. PubMed ID: 33515308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
    Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
    Elliot AH; Othman BN; Suzuki C; Blomqvist L; Martling A; Johansson H; Glimelius B; Nilsson PJ; Iversen H
    Anticancer Res; 2021 May; 41(5):2459-2465. PubMed ID: 33952471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.